International Institute of Cancer Immunology, Inc.

Haruo Sugiyama

Yoshihiro Oka

A tumor antigen that comprises, as an active ingredient, a product of the Wilms' tumor suppressor gene WT1 or a peptide composed of 7-30 contiguous amino acids containing an anchor amino acid for binding to major histocompatibility complex (MHC) class I in said amino acid sequence, and a vaccine comprising said antigen.

Tumor antigen based on products of the tumor suppressor gene WT1

A tumor antigen that comprises, as an active ingredient, a product of the Wilms', tumor suppressor gene WT1 or a peptide composed of 7&#x2013;30 contiguous amino acids containing an anchor amino acid for binding to major histocompatibility complex (MHC) class I in said amino acid sequence, and a vaccine comprising said antigen.

Growing community of inventors

Tondabayashi, Japan

Yoshihiro Oka